ANG Lifesciences India informs about outcome of board meeting

22 Nov 2017 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ANG Lifesciences India has informed that Board of Directors of the Company in its Meeting held on November 21, 2017 has considered and approved the Un-audited Financial Results for the Half Year ended September 30, 2017 along with Statement of Assets and Liabilities as at September 30, 2017 and the Limited Review Report of the Auditors thereon.

The above information is a part of company’s filings submitted to BSE.

ANG Lifesciences Share Price

28.28 -0.53 (-1.84%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×